Insmed Inc (NASDAQ: INSM) kicked off on Tuesday, down -0.84% from the previous trading day, before settling in for the closing price of $96.95. Over the past 52 weeks, INSM has traded in a range of $60.40-$106.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -13.12% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 6.03%. With a float of $185.72 million, this company’s outstanding shares have now reached $189.95 million.
In an organization with 1271 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 76.16%, operating margin of -230.21%, and the pretax margin is -264.87%.
Insmed Inc (INSM) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 2.23%, while institutional ownership is 104.67%. The most recent insider transaction that took place on Jul 07 ’25, was worth 5,535,591. Before that another transaction happened on Jul 01 ’25, when Company’s Chair and CEO sold 6,830 for $98.33, making the entire transaction worth $671,612. This insider now owns 233,924 shares in total.
Insmed Inc (INSM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 6.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 47.52% during the next five years compared to -13.12% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Take a look at Insmed Inc’s (INSM) current performance indicators. Last quarter, stock had a quick ratio of 5.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 47.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.95, a number that is poised to hit -1.30 in the next quarter and is forecasted to reach -3.67 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Let’s dig in a bit further. During the last 5-days, its volume was 2.67 million. That was inferior than the volume of 2.8 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 14.90%.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 76.98%, which indicates a significant increase from 9.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.83 in the past 14 days, which was lower than the 3.08 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $80.80, while its 200-day Moving Average is $75.42. However, in the short run, Insmed Inc’s stock first resistance to watch stands at $97.08. Second resistance stands at $98.03. The third major resistance level sits at $98.62. If the price goes on to break the first support level at $95.55, it is likely to go to the next support level at $94.96. The third support level lies at $94.01 if the price breaches the second support level.
Insmed Inc (NASDAQ: INSM) Key Stats
The company with the Market Capitalisation of 18.26 billion has total of 189,713K Shares Outstanding. Its annual sales at the moment are 363,710 K in contrast with the sum of -913,770 K annual income. Company’s last quarter sales were recorded 92,820 K and last quarter income was -256,580 K.
